Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fobi AI Inc V.FOBI

Alternate Symbol(s):  FOBIF

Fobi AI Inc. is a Canada-based artificial intelligence (AI) and data intelligence company. The Company operates in the technology industry and sells software as a service (SaaS), reselling, referring, and licensing its technology to licensors. The Company enables businesses to action, leverage, and monetize their customer data by powering personalized and data-driven customer experiences. The Company provides solutions, such as data, wallet passes, coupon platform, and marketing services. Its Sunflora is a global health and wellness retailer in the United States. Its wallet pass platforms deliver personalized, digital experiences directly through the mobile wallet. Wallet apps are used to save digital passes like coupons, membership cards, and event tickets as well as means of payment like credit cards. Its marketing services offer copywriting, blog post writing, video production, podcast production, photo editing, and more. It also offers a Qples SaaS coupon management platform.


TSXV:FOBI - Post by User

Comment by jdfm22on Feb 29, 2024 1:18pm
117 Views
Post# 35906996

RE:RE:Q one

RE:RE:Q oneYup.  FOBI has over the years accumulated a deficit.  In general, most, if not all listed companies at one time or another have an accumlated deficit.

To put FOBI's deficit into perspective, one of my other investments is in Alnylam Pharmaceuticals.  Owned it since 2007.

Current Market Cap: ~ $19 billion USD
Accumulated Deficit Since 2004: ~ $7 billion USD
Not Yet Cash Flow Positive: CF+ expected in 2025
Reveneue for 2023: ~$1.2 billion USD and growing.

WebLink to Alnylam Pharmaceuticals:
 
https://www.alnylam.com


(Note: this is not a financial recommendation or endorsement.  I am not a professional financial analyst or financial planner or advisor.  Do your own Due Diligence and/or seek the advice/help of a professional advisor)

FOBI is debt free.  Yes, they have an accumulated deficit.  But look up any company's security history and you will find accumulated deficits in all of them.  Give FOBI time.  I am very happy that I gave Alnylam time and I continue to hold Alnylam.  I hold FOBI as well.

Hope that this information was helpful and of interest to some.

Cheers and stay informed, jdfm22
<< Previous
Bullboard Posts
Next >>